-Business Standard Intellectual property policy should focus on implementation A preliminary draft of a new intellectual property rights policy for India has been the occasion for much discussion. Commerce Minister Nirmala Sitharaman even felt it necessary to assert on Twitter that the proposed revamp is not meant to appease the United States, given that this remains a major outstanding irritant in relations between the two countries. The government has argued that the...

-The Hindu Tropical diseases have often been neglected by pharmaceuticals because the size of the drug market is smaller, people have lower incomes and companies are uncertain about IPR January marked an important breakthrough in the fight against tropical diseases. Researchers and the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Delhi found a drug candidate that prevented TB and malaria pathogens from infecting human blood cells. It is not just that...

-The Indian Express "If we did not have a patent system, it would be irresponsible, on the basis of our present knowledge of its economic consequences, to recommend instituting one." So said Fritz Machlup, a wise American economist several decades ago. His words remain as true now as they were then. For, the patent system is one of the most faulty legal regimes that one could possibly have conceived. It purports...

-Livemint.com   The interim injunction has been granted till Cipla's application for Compulsory Licensing of the drug is decided   New Delhi: The Delhi high court on Friday restrained homegrown generic drug maker Cipla Ltd from making and selling Indacaterol, a drug claimed to be patented by Swiss pharma company Novartis AG. Indacaterol is a respiratory drug used in the treatment of chronic obstructive pulmonary disease and is sold under the brand name Onbrez. Please...

-Deccan Chronicle Prime Minister Narendra Modi may be patting himself on the back because President Barack Obama has agreed to India's position on food stockholding norms in World Trade Organisation (WTO). However, New Delhi seems to be bending over backwards to accommodate the American government and giant multinational corporations (MNCs) in the pharmaceutical industry, which will work to the detriment of our country's interests. In less than six months, the Modi government...